Replies to post #237913 on Amarin Corp Plc (AMRN)

[VuBru]

Kiwi - That was the key to the patent examiner. The patent considers all the biomarker changes as a group - decreased TGs, no increase in HDL, AND reduced Apo B. Not sure there was convincing prior prior art regarding the ApoB component, which was why the patent was issued.